BioQ Pharma to Present at the JMP Securities Life Sciences ConferenceSAN FRANCISCO, Jun. 08, 2016: BioQ Pharma, a specialty pharmaceutical company focused on the development and commercialization of large volume ready-to-use infusible pharmaceuticals, announced today that the Company will be presenting at the JMP Securities Life Sciences Conference to be held in New York City on June 21st and 22nd, 2016.
Josh Kriesel, President and Chief Executive Officer, is scheduled to present on Wednesday, June 22nd at 11:00 a.m. Eastern Daylight Time.
About BioQ Pharma
BioQ Pharma Incorporated is a privately held specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals. The Company's infusion platform is intended to address some of the most pressing unmet needs in drug infusion today: cost, medication error, sterility, efficiency, and patient quality of life. BioQ Pharma's vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via the Company's proprietary unit-dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. The Company is ISO13485 certified. BioQ Pharma's commercial collaborators and strategic partners include Novartis' Sandoz unit, Cipla, Lee's Pharm, Lunatus, and West Pharmaceutical Services.